BIRC5 and neoplasm: While these findings warrant studies in larger cohorts, one can speculate that they reflect mobilization of new CD8+ T-cell clones, that are possibly naïve-like and directed against other tumor-associated antigens beyond survivin, as indicated by our transcriptome-based analyses (figure 4D).